Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Merck & Co., Inc. (MRK) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Merck & Co., Inc. (MRK), most recent 12 months reported: revenue $66.57B, net income $3.17B, free cash flow $16.06B. Latest balance sheet on file: liquid cash $7.14B, total debt $53.91B, net cash -$46.77B. From SEC filings. More on Merck & Co., Inc.: Revenue · Profitability · Cash flow · Debt · Dividends Others in Pharmaceutical Preparations: Johnson & Johnson · ELI LILLY AND COMPANY · AbbVie Inc. · PFIZER INC · BRISTOL-MYERS SQUIBB COMPANY · ABBOTT LABORATORIES · Universe Pharmaceuticals INC · TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Stock screener

Watchlist